EUCTR2013-002395-40-BE进行中（未招募）1 期
Prospective intervention trial with adjuvant metformin in girls and boys with classic CAH (METFOR CAH). - METFOR CAH
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients: Girls and boys with classic CAH due to 21-hydroxylase deficiency (salt-wasting” and simple virilizing” forms), reaching the age of 8 years (girls) and 9 years (boys) in the period 2014 – 2018.
- •Controls: Girls and boys with classic CAH due to 21-hydroxylase deficiency (salt-wasting” and simple virilizing” forms), who are between 8 (girls) or 9 (boys) and 16 years at start of the study.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 90
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Affected children on glucocorticoid treatment other than HC.
- •Mental retardation (IQ<70), syndromic patients.
研究者
相似试验
尚未招募
2 期
Prospective randomized trial of an adjuvant therapy of completely resected Merkel Cell Carcinoma (MCC) with immune checkpoint blocking antibodies (Nivolumab, Opdivo®; Ipilimumab, Yervoy®) versus observatioNL-OMON50102niversity Hospital Essen30
进行中（未招募）
1 期
Comparison of therapy of Merkel Cell Carcinoma (MCC) with Ipilimumab (Yervoy®) or Nivolumab (Opdivo®) versus observation onlycompletely resected Merkel cell carcinomaMedDRA version: 21.1Level: LLTClassification code 10064025Term: Merkel cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-000043-78-DEniversity of Essen190
进行中（未招募）
1 期
Comparison of therapy of Merkel Cell Carcinoma (MCC) with Ipilimumab (Yervoy®) or Nivolumab (Opdivo®) versus observation onlyEUCTR2013-000043-78-NLniversity of Essen190
已完成
不适用
A prospective randomised trial of adjuvant chemotherapy in node positive early stage carcinoma of the cervixCervix cancerMalignant neoplasm of cervix uteriCancerISRCTN52711596Cancer Research UK (CRUK) (UK)
已完成
3 期
A phase III randomized trial of adjuvant therapy with irsogladine maleate for the patient with completely resected non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000005901Japanese Northern East Area Thoracic Surgery Study Group (JNETS)310